04 Oct 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US.
Dr Gormley will also continue in his existing roles as president, Daiichi Sankyo Pharma Development; global head of R&D and senior executive officer of Daiichi Sankyo, US.
In addition, Dr Greg Barrett has been appointed as the new acting head of the commercial division of Daiichi Sankyo, US. Both the appointments are effective as of October 3, 2013.
Former president and CEO, and head of the commercial division of Daiichi Sankyo, Dr John Gargiulo, has left the company effective October 3, 2013.